26 results on '"Okuzono S"'
Search Results
2. Case study of a cut slope failure in diatom earth
- Author
-
Yashima, A., primary, Shigematsu, H., additional, Okuzono, S., additional, and Nishio, M., additional
- Published
- 2021
- Full Text
- View/download PDF
3. An Insight into the Characteristics of a Nucleation Catalyst in CFC-Free Rigid Foam Systems
- Author
-
Yoshimura, H., primary, Tamano, Y., additional, Okuzono, S., additional, and Lowe, D. W., additional
- Published
- 1996
- Full Text
- View/download PDF
4. Key Aspects of Novel Catalyst Systems in all-Water Blown Integral Skin Foams-Related Catalytic Activities in the Isocyanate Reaction
- Author
-
Okuzono, S., primary, Kisaka, H., additional, Tamano, Y., additional, and Lowe, D. W., additional
- Published
- 1995
- Full Text
- View/download PDF
5. Key Aspects of Novel Catalyst Systems in All-Water Blown Integral Skin Foams-Related Catalytic Activities in the Isocyanate Reaction
- Author
-
Okuzono, S., primary, Kisaka, H., additional, Tamano, Y., additional, and Lowe, D.W., additional
- Published
- 1993
- Full Text
- View/download PDF
6. Die Mikrotaktizität von Polyacrylestern
- Author
-
Matsuzaki K., Uryu, T., Kanai, T., Hosonuma, K., Matsubara, T., Tachikawa, H., Yamada, M., and Okuzono, S.
- Published
- 1978
- Full Text
- View/download PDF
7. Characterization of Innovative Tertiary Amine Catalyst Systems for Water-Blown Flexible Polyurethane Foams
- Author
-
Okuzono, S., primary, Yoshimura, H., additional, Arai, S., additional, and Lowe, D.W., additional
- Published
- 1992
- Full Text
- View/download PDF
8. Characterization of Innovative Tertiary Amine Catalyst Systems for All Water Blown Flexible Polyurethane Foams
- Author
-
Okuzono, S., primary, Yoshimura, H., additional, Lowe, D.W., additional, and Arai, S., additional
- Published
- 1991
- Full Text
- View/download PDF
9. Innovative Tertiary Amine Catalyst Systems for CFC Free All MDI Based HR Foam
- Author
-
Yoshimura, H., primary, Okuzono, S., additional, Arai, S., additional, and Lowe, D.W., additional
- Published
- 1990
- Full Text
- View/download PDF
10. An N-terminal and ankyrin repeat domain interactome of Shank3 identifies the protein complex with the splicing regulator Nono in mice.
- Author
-
Okuzono S, Fujii F, Setoyama D, Taira R, Shinmyo Y, Kato H, Masuda K, Yonemoto K, Akamine S, Matsushita Y, Motomura Y, Sakurai T, Kawasaki H, Han K, Kato TA, Torisu H, Kang D, Nakabeppu Y, Ohga S, and Sakai Y
- Subjects
- Animals, Mice, Ankyrin Repeat, DNA-Binding Proteins metabolism, DNA-Binding Proteins genetics, Microfilament Proteins metabolism, Microfilament Proteins genetics, RNA Splicing, Brain metabolism, Seizures metabolism, Seizures genetics, Seizures chemically induced, Humans, Protein Binding, Mice, Inbred C57BL, Nerve Tissue Proteins metabolism, Nerve Tissue Proteins genetics, RNA-Binding Proteins metabolism, RNA-Binding Proteins genetics, Mice, Knockout
- Abstract
An autism-associated gene Shank3 encodes multiple splicing isoforms, Shank3a-f. We have recently reported that Shank3a/b-knockout mice were more susceptible to kainic acid-induced seizures than wild-type mice at 4 weeks of age. Little is known, however, about how the N-terminal and ankyrin repeat domains (NT-Ank) of Shank3a/b regulate multiple molecular signals in the developing brain. To explore the functional roles of Shank3a/b, we performed a mass spectrometry-based proteomic search for proteins interacting with GFP-tagged NT-Ank. In this study, NT-Ank was predicted to form a variety of complexes with a total of 348 proteins, in which RNA-binding (n = 102), spliceosome (n = 22), and ribosome-associated molecules (n = 9) were significantly enriched. Among them, an X-linked intellectual disability-associated protein, Nono, was identified as a NT-Ank-binding protein. Coimmunoprecipitation assays validated the interaction of Shank3 with Nono in the mouse brain. In agreement with these data, the thalamus of Shank3a/b-knockout mice aberrantly expressed splicing isoforms of autism-associated genes, Nrxn1 and Eif4G1, before and after seizures with kainic acid treatment. These data indicate that Shank3 interacts with multiple RNA-binding proteins in the postnatal brain, thereby regulating the homeostatic expression of splicing isoforms for autism-associated genes after birth., (© 2024 The Author(s). Genes to Cells published by Molecular Biology Society of Japan and John Wiley & Sons Australia, Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
11. Gnao1 is a molecular switch that regulates the Rho signaling pathway in differentiating neurons.
- Author
-
Taira R, Akamine S, Okuzono S, Fujii F, Hatai E, Yonemoto K, Takemoto R, Kato H, Masuda K, Kato TA, Kira R, Tsujimura K, Yamamura K, Ozaki N, Ohga S, and Sakai Y
- Subjects
- Humans, Mice, Animals, rho-Associated Kinases metabolism, Organoids metabolism, Amides pharmacology, Pyridines, GTP-Binding Protein alpha Subunits, Gi-Go metabolism, GTP-Binding Protein alpha Subunits, Gi-Go genetics, Neurons metabolism, Signal Transduction, Induced Pluripotent Stem Cells metabolism, Induced Pluripotent Stem Cells cytology, rho GTP-Binding Proteins metabolism, rho GTP-Binding Proteins genetics, Cell Differentiation
- Abstract
GNAO1 encodes G protein subunit alpha O1 (Gαo). Pathogenic variations in GNAO1 cause developmental delay, intractable seizures, and progressive involuntary movements from early infancy. Because the functional role of GNAO1 in the developing brain remains unclear, therapeutic strategies are still unestablished for patients presenting with GNAO1-associated encephalopathy. We herein report that siRNA-mediated depletion of Gnao1 perturbs the expression of transcripts associated with Rho GTPase signaling in Neuro2a cells. Consistently, siRNA treatment hampered neurite outgrowth and extension. Growth cone formation was markedly disrupted in monolayer neurons differentiated from iPSCs from a patient with a pathogenic variant of Gαo (p.G203R). This variant disabled neuro-spherical assembly, acquisition of the organized structure, and polarized signals of phospho-MLC2 in cortical organoids from the patient's iPSCs. We confirmed that the Rho kinase inhibitor Y27632 restored these morphological phenotypes. Thus, Gαo determines the self-organizing process of the developing brain by regulating the Rho-associated pathway. These data suggest that Rho GTPase pathway might be an alternative target of therapy for patients with GNAO1-associated encephalopathy., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
12. ATP1A3 regulates protein synthesis for mitochondrial stability under heat stress.
- Author
-
Fujii F, Kanemasa H, Okuzono S, Setoyama D, Taira R, Yonemoto K, Motomura Y, Kato H, Masuda K, Kato TA, Ohga S, and Sakai Y
- Subjects
- Humans, Animals, Mice, Eukaryotic Initiation Factor-4G metabolism, Neurons metabolism, Phosphorylation, Protein Binding, Calcium metabolism, Sodium-Potassium-Exchanging ATPase metabolism, Mitochondria metabolism, Protein Biosynthesis, Induced Pluripotent Stem Cells metabolism, Heat-Shock Response
- Abstract
Pathogenic variants in ATP1A3, the gene encoding the α3 subunit of the Na+/K+-ATPase, cause alternating hemiplegia of childhood (AHC) and related disorders. Impairments in Na+/K+-ATPase activity are associated with the clinical phenotype. However, it remains unclear whether additional mechanisms are involved in the exaggerated symptoms under stressed conditions in patients with AHC. We herein report that the intracellular loop (ICL) of ATP1A3 interacted with RNA-binding proteins, such as Eif4g (encoded by Eif4g1), Pabpc1 and Fmrp (encoded by Fmr1), in mouse Neuro2a cells. Both the siRNA-mediated depletion of Atp1a3 and ectopic expression of the p.R756C variant of human ATP1A3-ICL in Neuro2a cells resulted in excessive phosphorylation of ribosomal protein S6 (encoded by Rps6) and increased susceptibility to heat stress. In agreement with these findings, induced pluripotent stem cells (iPSCs) from a patient with the p.R756C variant were more vulnerable to heat stress than control iPSCs. Neurons established from the patient-derived iPSCs showed lower calcium influxes in responses to stimulation with ATP than those in control iPSCs. These data indicate that inefficient protein synthesis contributes to the progressive and deteriorating phenotypes in patients with the p.R756C variant among a variety of ATP1A3-related disorders., Competing Interests: Competing interests The authors declare no competing or financial interests., (© 2024. Published by The Company of Biologists Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
13. A Scoping Review of Interventions to Improve Occupational Safety and Health of Construction Workers.
- Author
-
Hayashi H, Li Y, Sussman DD, Okuzono S, Viswanath K, and Kawachi I
- Subjects
- Humans, Behavior Therapy, Occupational Health, Construction Industry
- Abstract
Objective: This review comprehensively examines interventions which sought to improve the occupational safety and/or health of construction workers. Factors that explain the (in)effectiveness of interventions were also summarized., Data Source: This review consisted of a search using two electronic databases, PubMed and Web of Science., Study Inclusion and Exclusion Criteria: Targeted workers in the construction industry; had at least one primary outcome that aimed to improve occupational safety and/or health; were published between January 01, 1990 and December 01, 2019; and were written in English., Data Extraction and Synthesis: Two researchers independently carried out the process of reviewing the titles, abstracts and full texts, and extracted all data. If there were differences, discussions were held until a consensus was reached., Results: A total of 1297 articles were retrieved and 24 were selected for final evaluation. Seventeen studies reported significant intervention effects, while 7 found their primary outcome not significantly improved., Conclusion: Future research should place more effort on interventions aimed at improving both occupational safety and health outcomes in an integrated manner, with environmental interventions that accompany behavioral interventions at the individual level. Besides, additional effort is also needed to ensure the involvement of relevant stakeholders in designing the intervention, avoiding contamination effects (through cluster randomization), optimizing the "dosage" of intervention, and improving measurement of outcomes., Competing Interests: Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- Published
- 2023
- Full Text
- View/download PDF
14. Heterogeneity and mitochondrial vulnerability configurate the divergent immunoreactivity of human induced microglia-like cells.
- Author
-
Yonemoto K, Fujii F, Taira R, Ohgidani M, Eguchi K, Okuzono S, Ichimiya Y, Sonoda Y, Chong PF, Goto H, Kanemasa H, Motomura Y, Ishimura M, Koga Y, Tsujimura K, Hashiguchi T, Torisu H, Kira R, Kato TA, Sakai Y, and Ohga S
- Subjects
- Humans, Lipopolysaccharides pharmacology, Flow Cytometry, Gene Expression, Microglia metabolism, Neuroinflammatory Diseases
- Abstract
Microglia play versatile roles in progression of and protection against neuroinflammatory diseases. Little is known, however, about the mechanisms underlying the diverse reactivity of microglia to inflammatory conditions. We investigated how human induced microglia-like (iMG) cells respond to innate immune ligands. Quantitative PCR showed that poly-I:C and lipopolysaccharide (LPS) activated the expression of IL1B and TNF. Immunoreactivity of iMG did not differ between controls (n = 11) and patients with neuroinflammatory diseases (n = 24). Flow cytometry revealed that CD14
high cells expressed interleukin (IL) -1β after LPS treatment. Immunoblotting showed that poly-I:C and LPS differentially activated inflammatory pathways but commonly induced mitochondrial instability and the expression of pyruvate kinase isoform M2 (PKM2). Furthermore, a potent stimulator of PKM2 (DASA-58) alleviated IL-1β production after LPS treatment. These data indicate that heterogeneous cell populations and mitochondrial stability underlie the divergent immunoreactivity of human iMG in environments., Competing Interests: Declaration of Competing Interest None., (Copyright © 2023 Elsevier Inc. All rights reserved.)- Published
- 2023
- Full Text
- View/download PDF
15. Shank3a/b isoforms regulate the susceptibility to seizures and thalamocortical development in the early postnatal period of mice.
- Author
-
Okuzono S, Fujii F, Matsushita Y, Setoyama D, Shinmyo Y, Taira R, Yonemoto K, Akamine S, Motomura Y, Sanefuji M, Sakurai T, Kawasaki H, Han K, Kato TA, Torisu H, Kang D, Nakabeppu Y, Sakai Y, and Ohga S
- Subjects
- Mice, Animals, Seizures, Thalamic Nuclei, Mice, Knockout, Protein Isoforms genetics, Microfilament Proteins metabolism, Nerve Tissue Proteins metabolism, Autism Spectrum Disorder
- Abstract
Epileptic seizures are distinct but frequent comorbidities in children with autism spectrum disorder (ASD). The hyperexcitability of cortical and subcortical neurons appears to be involved in both phenotypes. However, little information is available concerning which genes are involved and how they regulate the excitability of the thalamocortical network. In this study, we investigate whether an ASD-associated gene, SH3 and multiple ankyrin repeat domains 3 (Shank3), plays a unique role in the postnatal development of thalamocortical neurons. We herein report that Shank3a/b, the splicing isoforms of mouse Shank3, were uniquely expressed in the thalamic nuclei, peaking from two to four weeks after birth. Shank3a/b-knockout mice showed lower parvalbumin signals in the thalamic nuclei. Consistently, Shank3a/b-knockout mice were more susceptible to generalized seizures than wild-type mice after kainic acid treatments. Together, these data indicate that NT-Ank domain of Shank3a/b regulates molecular pathways that protect thalamocortical neurons from hyperexcitability during the early postnatal period of mice., Competing Interests: Conflict of interest The authors declare no competing interests., (Copyright © 2023. Published by Elsevier B.V.)
- Published
- 2023
- Full Text
- View/download PDF
16. Translational pediatrics: clinical perspective for Phelan-McDermid syndrome and autism research.
- Author
-
Sakai Y, Okuzono S, Schaaf CP, and Ohga S
- Subjects
- Child, Chromosome Deletion, Chromosome Disorders, Chromosomes, Human, Pair 22 genetics, Humans, Nerve Tissue Proteins genetics, Autism Spectrum Disorder genetics, Autism Spectrum Disorder therapy, Autistic Disorder genetics, Autistic Disorder therapy, Pediatrics
- Abstract
Phelan-McDermid syndrome (PMS) is a rare genetic disorder presenting with developmental delay, epilepsy, and autism spectrum disorder (ASD). The segmental deletion of chromosome 22q13.3 affects the copy number of SHANK3, the gene encoding a scaffolding protein at the postsynaptic density. Biological studies indicate that SHANK3 plays crucial roles in the development of synaptic functions in the postnatal brain. Notably, induced pluripotent stem (iPS) cells have enabled researchers to develop brain organoids and microglia from patients and to explore the pathophysiology of neurodevelopmental disorders in human cells. Single-cell RNA sequencing of these cells revealed that human-specific genes are uniquely expressed during cortical development. Thus, patient-derived disease models are expected to identify as-yet-unidentified functions of SHANK3 in the development of human brain. These efforts may help establish a new style of translational research in pediatrics, which is expected to provide therapeutic insight for children with PMS and broader categories of disease. IMPACT: Phelan-McDermid syndrome is a prototypic model for molecular studies of autism spectrum disorder. Brain organoids are expected to provide therapeutic insight. Single-cell RNA sequencing of microglia may uncover the functional roles of human-specific genes., (© 2021. The Author(s), under exclusive licence to the International Pediatric Research Foundation, Inc.)
- Published
- 2022
- Full Text
- View/download PDF
17. Vitamin A deficiency-associated corneal perforation in a boy with autism spectrum disorder: A case report and literature review.
- Author
-
Adachi S, Torio M, Okuzono S, Motomura Y, Ichimiya Y, Sonoda Y, Nagata J, Okamoto M, Notomi S, Sanefuji M, Sakai Y, and Ohga S
- Subjects
- Child, Dietary Supplements, Humans, Male, Autism Spectrum Disorder complications, Corneal Perforation, Vitamin A Deficiency complications, Vitamin D Deficiency
- Abstract
Background: Malnutrition and vitamin deficiency are growing concerns in the clinical management of children with autism spectrum disorder (ASD). This case report presents a boy with ASD who developed vitamin A deficiency during follow-up., Case Report: A 7-y-old boy had been diagnosed with ASD and developmental delay at age 18 mo. He developed convulsions associated with hypocalcemia and vitamin D deficiency at 3 y of age. Although vitamin D supplementation was continued, he was only able to eat rice, green tea, and fried potatoes from 3 y of age to age 7 y. He had started rubbing his eyes and had refused to open his eyes 9 mo before. An ophthalmologic examination showed bilateral corneal ulcers and right corneal perforation. Vitamin A was immediately supplemented with a nasogastric tube; however, his right eye was surgically enucleated against the persistent infection., Literature Review: A search of the relevant literature from 1993 to 2020 identified 11 cases of patients with ASD (5-17 y of age) who developed vitamin A deficiency owing to malnutrition. Only 4 cases (36%) had a full recovery in visual acuity., Conclusion: Vitamin A deficiency frequently causes irreversible visual impairment in children with ASD. Vigilant monitoring of vitamin levels prevents unfavorable outcomes in children with ASD and difficulty in food intake., (Copyright © 2021 Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
18. GNAO1 organizes the cytoskeletal remodeling and firing of developing neurons.
- Author
-
Akamine S, Okuzono S, Yamamoto H, Setoyama D, Sagata N, Ohgidani M, Kato TA, Ishitani T, Kato H, Masuda K, Matsushita Y, Ono H, Ishizaki Y, Sanefuji M, Saitsu H, Matsumoto N, Kang D, Kanba S, Nakabeppu Y, Sakai Y, and Ohga S
- Subjects
- Animals, Brain metabolism, Brain Diseases metabolism, Cells, Cultured, Humans, Mice, Mice, Inbred C57BL, Neurodevelopmental Disorders metabolism, Neurons metabolism, Phenotype, Cytoskeleton metabolism, GTP-Binding Protein alpha Subunits, Gi-Go metabolism
- Abstract
Developmental and epileptic encephalopathy (DEE) represents a group of neurodevelopmental disorders characterized by infantile-onset intractable seizures and unfavorable prognosis of psychomotor development. To date, hundreds of genes have been linked to the onset of DEE. GNAO1 is a DEE-associated gene encoding the alpha-O1 subunit of guanine nucleotide-binding protein (Gα
O ). Despite the increasing number of reported children with GNAO1 encephalopathy, the molecular mechanisms underlying their neurodevelopmental phenotypes remain elusive. We herein present that co-immunoprecipitation and mass spectrometry analyses identified another DEE-associated protein, SPTAN1, as an interacting partner of GαO . Silencing of endogenous Gnao1 attenuated the neurite outgrowth and calcium-dependent signaling. Inactivation of GNAO1 in human-induced pluripotent stem cells gave rise to anomalous brain organoids that only weakly expressed SPTAN1 and Ankyrin-G. Furthermore, GNAO1-deficient organoids failed to conduct synchronized firing to adjacent neurons. These data indicate that GαO and other DEE-associated proteins organize the cytoskeletal remodeling and functional polarity of neurons in the developing brain., (© 2020 The Authors. The FASEB Journal published by Wiley Periodicals LLC on behalf of Federation of American Societies for Experimental Biology.)- Published
- 2020
- Full Text
- View/download PDF
19. An acute encephalopathy with reduced diffusion in BRAF-associated cardio-facio-cutaneous syndrome.
- Author
-
Okuzono S, Fukai R, Noda M, Miyake N, Lee S, Kaku N, Sanefuji M, Akamine S, Kanno S, Ishizaki Y, Torisu H, Kira R, Matsumoto N, Sakai Y, and Ohga S
- Subjects
- Abnormalities, Multiple genetics, Brain Diseases complications, Brain Diseases genetics, Child, Drug Resistant Epilepsy complications, Ectodermal Dysplasia complications, Facies, Failure to Thrive complications, Heart Defects, Congenital complications, Humans, Magnetic Resonance Imaging methods, Male, Mutation, Proto-Oncogene Proteins B-raf physiology, Brain Diseases etiology, Ectodermal Dysplasia physiopathology, Failure to Thrive physiopathology, Heart Defects, Congenital physiopathology, Proto-Oncogene Proteins B-raf genetics
- Abstract
Background: Cardio-facio-cutaneous syndrome (CFCS) is a rare genetic disorder characterized by cardiovascular anomalies, dysmorphic faces, ectodermal abnormalities and developmental delays. Mutations in BRAF and other RAS-MAPK pathway-associated genes are commonly identified in patients with CFCS. While this molecular pathway is known to be associated with neuro-inflammatory conditions, only one case with CFCS has been reported thus far to develop acute encephalopathy in childhood., Case Report: A 3-year-old boy with dysmorphic features and mild psychomotor delay developed acute encephalopathy. After a 45-min long, generalized seizure, the magnetic resonance imaging revealed that the restricted diffusion signals spread to the bilateral subcortical white matters on day 1 of illness. Despite the 14 days of intensive care, the acute symptoms of encephalopathy left him intractable epilepsy and severe neurocognitive impairments. The whole-exome sequencing analysis identified a de novo heterozygous mutation of BRAF (NM_004333:p.Thr241Met) in this case., Conclusion: The present case suggests that the hyperactive condition of ERK signals might augment the development of acute encephalopathy and post-encephalopathic epilepsy in childhood., (Copyright © 2018 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
20. Streptococcus pyogenes-purpura fulminans as an invasive form of group A streptococcal infection.
- Author
-
Okuzono S, Ishimura M, Kanno S, Sonoda M, Kaku N, Motomura Y, Nishio H, Oba U, Hanada M, Fukushi JI, Urata M, Kang D, Takada H, and Ohga S
- Subjects
- Aged, Child, Child, Preschool, Fatal Outcome, Female, Humans, Infant, Male, Middle Aged, Treatment Outcome, Anti-Bacterial Agents therapeutic use, Purpura Fulminans pathology, Purpura Fulminans therapy, Streptococcal Infections drug therapy, Streptococcal Infections pathology, Streptococcus pyogenes drug effects, Streptococcus pyogenes pathogenicity
- Abstract
Background: Streptococcus pyogenes is an uncommon pathogen of purpura fulminans, and the pathogenesis of S. pyogenes-purpura fulminans remains unclear because of paucity of cases. We reported a pediatric case of S. pyogenes-purpura fulminans with literature review of the disease., Case Presentation: A 3-year-old boy showed limping, lethargy and acral gangrene within 24 h. A diagnosis of S. pyogenes-purpura fulminans was made for bacterial isolation from throat and peripheral blood. Intensive therapy led to a survival with amputation of the left distal metatarsal bone, and normal development. The isolated M12 carried no mutation of csrS/R or rgg. Thrombophilia or immunodeficiency was excluded., Discussion: Twelve-reported cases (9 pediatric and 3 elderly) of S. pyogenes-purpura fulminans started with shock and coagulopathy. Five patients age < 8 years had no underlying disease and survived. One youngest and two immunocompromised patients died., Conclusion: Streptococcus pyogenes-acute infectious purpura fulminans is a distinctive rare form of aggressive GAS infections.
- Published
- 2018
- Full Text
- View/download PDF
21. Spanking and subsequent behavioral problems in toddlers: A propensity score-matched, prospective study in Japan.
- Author
-
Okuzono S, Fujiwara T, Kato T, and Kawachi I
- Subjects
- Child, Preschool, Epidemiologic Methods, Female, Humans, Japan epidemiology, Male, Parenting psychology, Parents psychology, Problem Behavior psychology, Punishment psychology
- Abstract
Harsh or frequent spanking in early childhood is an established risk factor for later childhood behavioral problems as well as mental disorder in adulthood in Western societies. However, few studies have been conducted in Asian populations, where corporal punishment is relatively accepted. Moreover, the impacts of occasional spanking on subsequent behavioral problems remain uncertain. This study sought to investigate prospectively the association between the frequency of spanking of toddlers and later behavioral problems in Japanese children using national birth cohort data. We used data from the Longitudinal Survey of Newborns in the 21st Century, a population-based birth cohort data set collected by the Japanese Ministry of Health, Labour, and Welfare (N=29,182). Frequency of spanking ("never", "sometimes" and "always") and child behavioral problems were assessed via a caregiver questionnaire when the child was 3.5 years old and again at 5.5 years. Propensity score matching was used to examine the association between frequency of spanking and child behavioral problems, adjusting for parental socioeconomic status, child temperament and parenting behaviors. Compared to children who were never spanked, occasional spanking ("sometimes") showed a higher number of behavioral problems (on a 6-point scale) (coefficient: 0.11, 95% CI: 0.07-0.15), and frequent spanking ("always") showed an even larger number of behavioral problems compared with "sometimes" (coefficient: 0.08, 95% CI:0.01-0.16). Spanking of any self-reported frequency was associated with an increased risk for later behavioral problems in children., (Copyright © 2017 Elsevier Ltd. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
22. Evidence for structural differences between the two highly homologous actin-regulatory proteins, destrin and cofilin.
- Author
-
Arima K, Imanaka M, Okuzono S, Kazuta Y, and Kotani S
- Subjects
- Actin Depolymerizing Factors, Amino Acid Sequence, Chymotrypsin chemistry, Circular Dichroism, Destrin, Gene Expression, Hydrogen-Ion Concentration, Molecular Sequence Data, Plasmids chemistry, Protein Structure, Tertiary, Sequence Alignment, Sequence Analysis, Sequence Homology, Amino Acid, Subtilisins chemistry, Trypsin chemistry, Actins chemistry, Carrier Proteins chemistry, Cytoskeletal Proteins, Microfilament Proteins chemistry
- Abstract
The amino acid sequences of destrin and cofilin are very similar (84% homology) throughout the entire range of proteins, but they have different functions. In this study, we constructed a new cofilin expression plasmid, which had high expression frequency, and the structures of destrin and cofilin were analyzed by limited proteolysis and circular dichroism (CD). When destrin was digested by trypsin, two fragments of 17.0 kDa and 9.2 kDa were obtained, whereas only one 8.4 kDa fragment was obtained from cofilin. In spite of the overall sequence homology, an N-terminal amino acid sequence analyses of the fragments revealed the cleavage sites on destrin and cofilin to be different. These results suggest that destrin and cofilin differ in their overall tertiary folds. Cofilin showed activity similar to destrin at high pH values, although no pH-dependent structural change in cofilin was confirmed by using limited proteolysis and CD.
- Published
- 1998
- Full Text
- View/download PDF
23. Combined effects of vitamin E (alpha-tocopherol) and cisplatin on the growth of murine neuroblastoma in vivo.
- Author
-
Sue K, Nakagawara A, Okuzono S, Fukushige T, and Ikeda K
- Subjects
- Animals, Cisplatin administration & dosage, Female, Kidney metabolism, Liver metabolism, Mice, Mice, Inbred A, Neuroblastoma metabolism, Platinum metabolism, Time Factors, Vitamin E administration & dosage, Vitamin E metabolism, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Neuroblastoma drug therapy
- Abstract
Combined effects of vitamin E (alpha-tocopherol) and cisplatin on the growth of two murine neuroblastomas (C1300, NS-20) was investigated in vivo. Five groups of mice were prepared; group 1 were fed the control diet, group 2 were fed a vitamin E-deficient diet, group 3 were fed a vitamin E-supplemented diet, group 4 were fed the control diet and plus vitamin E solution given intraperitoneally during the treatment (solvent i.p. group), and group 5 were given vitamin E in the same manner (20 mg/kg/day; vitamin E i.p. group). Cisplatin (6 mg/kg) was injected intraperitoneally into the mice of each group during the treatment. In case of the C1300 neuroblastoma, the antitumor activity of cisplatin was most enhanced in the mice receiving vitamin E i.p., and the intra-tumor vitamin E and platinum levels were significantly higher in this group than in the other groups (P less than 0.01, and P less than 0.05 respectively). In contrast, in animals transplanted with the NS-20 murine neuroblastoma, which proved to be a cisplatin-tolerant tumor in separate experiments, no combined effect of those drugs was observed, although the intra-tumor level of platinum was elevated. The possibility was that vitamin E increases the influx of cisplatin into the tumor cells and acts after incorporation of cisplatin through the plasma membrane. Vitamin E did not accentuate the cisplatin-induced renal impairment in vitamin E-loaded groups. Those results suggested that vitamin E should be considered as a co-agent of cisplatin for the treatment of neuroblastoma.
- Published
- 1988
- Full Text
- View/download PDF
24. Different clonal drug sensitivity of murine neuroblastoma cells in vivo.
- Author
-
Okuzono S, Nakagawara A, Sue K, Fukushige T, and Ikeda K
- Subjects
- Aminoimidazole Carboxamide analogs & derivatives, Aminoimidazole Carboxamide pharmacology, Animals, Body Weight drug effects, Cisplatin pharmacology, Cyclophosphamide pharmacology, Dacarbazine pharmacology, Female, Mice, Mice, Inbred A, Tumor Cells, Cultured, Vincristine pharmacology, Antineoplastic Agents pharmacology, Clone Cells drug effects, Neuroblastoma pathology
- Abstract
Four cloned murine neuroblastomas were implanted intramuscularly into the left thigh of adult A/Jax mice. Cyclophosphamide, cisplatin, adriamycin, imidazole carboxamide, and vincristine were administered intraperitoneally, in a dose of one third to one fourth of a median lethal dose, every week after the implantation until all the mice died. The effects of continuous long-term chemotherapy, particularly on clonal differences, were then assessed. Cyclophosphamide was most effective for four murine neuroblastomas, and cisplatin was the next most effective drug. Cisplatin was not effective in the NS-20 cell line, a cholinergic cloned neuroblastoma. The C 1300 cell line (wild type) was tolerant to adriamycin, imidazole carboxamide, and vincristine. The N-18 cell line (an inactive clone) exhibited tolerance of adriamycin and imidazole carboxamide. In the N1E-115 cell line, an adrenergic clone, tumor growth was inhibited by all the drugs given. We conclude from this study that drug sensitivity differs with the clone, and that there are clones resistant to each drug.
- Published
- 1988
- Full Text
- View/download PDF
25. Different effects of vitamin E on the growth and morphological differentiation of 4 murine neuroblastoma cell lines in vitro.
- Author
-
Sué K, Nakagawara A, Okuzono S, Fukushige T, and Ikeda K
- Subjects
- Animals, Cell Line, Dose-Response Relationship, Drug, Drug Synergism, Mice, Neuroblastoma pathology, Tocopherols, Vitamin E pharmacology, Cell Division drug effects, Cisplatin pharmacology, Tumor Cells, Cultured drug effects, Vitamin E analogs & derivatives
- Abstract
The effects of vitamin E (vit.E, d-alpha-tocopherol acid succinate) on the growth and the morphological differentiation of 4 representative murine neuroblastoma cell lines: C1300 (wild type), NS-20 (cholinergic type), N-18 (inactive type), N1E-115 (adrenergic type), and the combined effects of vit.E and cis-diamminedichloroplatinum(II)(cisplatin, CDDP) were studied in culture. Vitamin E inhibited the growth of all clonal cells in a dose-dependent manner, especially that of NS-20 cells, and it caused significant morphological differentiation only in NS-20 cells. In addition, vit.E enhanced the growth inhibition of C1300 cells by cisplatin in an additive manner, but not that of NS-20 cells. These suggested that both phenomena induced by vit.E may not always occur in parallel in each clonal neuroblastoma, and both mechanisms might be different.
- Published
- 1988
- Full Text
- View/download PDF
26. [Cisplatin in the treatment of neuroblastoma--anti-tumor activity and nephrotoxicity in a single high-dose and repeated low-dose regimen].
- Author
-
Sue K, Ikeda K, Nakagawara A, Okuzono S, Fukushige T, and Higuchi S
- Subjects
- Animals, Body Weight drug effects, Cisplatin blood, Cisplatin pharmacology, Drug Administration Schedule, Mice, Neuroblastoma blood, Neuroblastoma pathology, Cisplatin administration & dosage, Kidney drug effects, Neuroblastoma drug therapy
- Published
- 1986
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.